Diabetic Retinopathy Treatment in Varanasi | Dr. Shantanu Gupta
Diabetic retinopathy can silently damage the retina and threaten vision, even before noticeable symptoms develop. Learn about its stages, the importance of OCT and detailed retinal examination, and how treatment options such as anti-VEGF injections, retinal laser and vitrectomy are selected according to disease severity. Dr. Shantanu Gupta discusses an individualised, evidence-based approach to diabetic eye care in Varanasi.
Diabetic Retinopathy: A Clinical Approach to Early Diagnosis, OCT Evaluation and Individualised Treatment
By Dr. Shantanu Kumar Gupta | Medical Retina Specialist, Varanasi
Diabetic retinopathy is one of the most important causes of preventable visual impairment among people living with diabetes. It develops when persistently elevated blood glucose damages the small blood vessels supplying the retina. In its early stages, the disease may produce no noticeable symptoms. By the time a patient experiences blurred vision, floaters or sudden visual loss, significant retinal damage may already have occurred.
The key to managing diabetic retinopathy is not simply identifying retinal haemorrhages or prescribing treatment. It requires accurate clinical staging, assessment of macular involvement, identification of retinal ischaemia and neovascularisation, and a treatment plan based on the actual disease activity.
At my practice in Varanasi, I approach diabetic retinal disease with an emphasis on detailed retinal examination, appropriate imaging, evidence-based treatment and regular follow-up.
Understanding the Different Stages of Diabetic Retinopathy
Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR). Diabetic macular oedema (DME) can develop at different stages and requires separate assessment.
1. Mild Non-Proliferative Diabetic Retinopathy
Mild NPDR is characterised predominantly by microaneurysms, which are small outpouchings of retinal capillaries.
Patients are generally asymptomatic at this stage. Vision may remain normal, and the changes are usually detected during a dilated retinal examination.
Management commonly involves:
Optimisation of blood glucose levels.
Control of blood pressure and lipid abnormalities.
Assessment of other systemic risk factors.
Periodic retinal examination based on the clinical findings.
Intravitreal injections or retinal laser are not routinely required for uncomplicated mild NPDR.
2. Moderate Non-Proliferative Diabetic Retinopathy
As the disease progresses, additional retinal changes may appear, including:
Retinal dot-and-blot haemorrhages.
Hard exudates.
Cotton-wool spots.
Increasing microaneurysms.
Mild venous abnormalities.
The severity of retinopathy and the presence or absence of macular oedema determine the follow-up plan.
A patient with moderate NPDR may have good visual acuity but still require careful monitoring because the disease can progress.
3. Severe Non-Proliferative Diabetic Retinopathy
Severe NPDR is identified using the established 4-2-1 rule. It is characterised by one or more of the following:
Severe haemorrhages and microaneurysms in all four quadrants.
Definite venous beading in at least two quadrants.
Prominent intraretinal microvascular abnormalities (IRMA) in at least one quadrant.
Patients with severe NPDR have a higher risk of progression to proliferative diabetic retinopathy.
Accurate documentation and appropriately timed follow-up are particularly important at this stage. Selected patients may need additional investigations or treatment depending on the clinical picture.
4. Proliferative Diabetic Retinopathy
Proliferative diabetic retinopathy develops when retinal ischaemia stimulates the growth of abnormal new blood vessels.
These vessels are fragile and can bleed into the vitreous cavity. Advanced disease may lead to:
Vitreous haemorrhage.
Fibrovascular proliferation.
Tractional retinal detachment.
Combined tractional and rhegmatogenous retinal detachment.
Severe and potentially irreversible visual loss.
Pan-retinal photocoagulation (PRP) remains an important treatment for proliferative diabetic retinopathy. Anti-VEGF injections may also have a role in selected cases.
Advanced cases with non-clearing vitreous haemorrhage or tractional retinal detachment may require vitreoretinal surgery.
Diabetic Macular Oedema: An Important Cause of Reduced Vision
Diabetic macular oedema (DME) occurs when fluid accumulates within or beneath the macula, the central part of the retina responsible for detailed vision.
It can develop in patients with NPDR or PDR.
Patients may complain of:
Blurred central vision.
Difficulty reading.
Distortion of straight lines.
Difficulty recognising faces.
Reduced contrast or clarity of vision.
The severity of macular oedema cannot always be judged by visual acuity alone. A patient may have relatively good vision despite significant retinal thickening, while another may have reduced vision due to chronic structural damage.
This is why OCT has become an essential investigation in the evaluation and monitoring of diabetic macular oedema.
The Role of OCT in Diabetic Retinopathy
Optical Coherence Tomography (OCT) provides cross-sectional images of the retinal layers and allows detailed assessment of macular structure.
It helps identify:
Intraretinal cystic spaces.
Retinal thickening.
Subretinal fluid.
Disruption of the outer retinal layers.
Epiretinal membrane or vitreomacular traction.
Chronic structural changes associated with diabetic macular disease.
OCT is particularly useful when deciding whether diabetic macular oedema is present, whether it is involving the centre of the macula and how it is responding to treatment.
Serial OCT scans also help assess treatment response and guide decisions about subsequent injections.
However, OCT should always be interpreted alongside visual acuity, dilated fundus examination and the patient's overall clinical findings. An abnormal scan does not automatically mean that an injection is necessary.
Why a Complete Retinal Evaluation Matters
A good diabetic eye evaluation should go beyond checking visual acuity and performing a basic fundus examination.
Depending on the patient's condition, a comprehensive assessment may include:
1. Visual acuity and anterior segment examination
This helps identify other possible causes of reduced vision, including cataract and corneal disease.
2. Dilated fundus examination
A detailed retinal examination helps identify microaneurysms, haemorrhages, exudates, cotton-wool spots, venous abnormalities, IRMA and neovascularisation.
3. OCT of the macula
This is particularly important when macular oedema is suspected or when visual acuity is reduced.
4. Fundus photography
Retinal photographs provide documentation of disease severity and help compare changes during subsequent visits.
5. Fundus fluorescein angiography (FFA), when indicated
FFA may help assess retinal capillary non-perfusion, vascular leakage, neovascularisation and areas of retinal ischaemia.
6. OCT angiography, in selected cases
OCT-A can provide additional information about retinal and choroidal vascular networks without intravenous dye.
Not every patient needs every investigation. The choice depends on the clinical findings and the question that needs to be answered.
For further information about available retinal investigations and treatments, visit the Medical Retina services page.
Treatment of Diabetic Retinopathy: Not Every Patient Needs an Injection or Laser
One of the most important principles in diabetic retinal care is selecting the right treatment for the right stage of disease.
Treatment decisions should be based on the type of retinopathy, macular involvement, retinal ischaemia, visual function and the expected benefit of intervention.
1. Observation and Systemic Risk-Factor Control
Patients with mild or selected moderate NPDR without diabetic macular oedema may only require observation and regular retinal monitoring.
Good control of:
Blood glucose.
Blood pressure.
Serum lipids.
Other relevant systemic risk factors.
is an important part of long-term management.
An eye injection or laser procedure is not a substitute for systemic diabetes management.
2. Anti-VEGF Injections for Diabetic Macular Oedema
Anti-VEGF medicines reduce the activity of vascular endothelial growth factor, a substance involved in abnormal vascular permeability and new blood vessel formation.
Intravitreal anti-VEGF injections are an established treatment for centre-involving diabetic macular oedema, particularly when vision is affected.
Medicines used in appropriate clinical situations include:
Ranibizumab.
Aflibercept.
Bevacizumab.
The choice of medicine and treatment schedule depend on the clinical indication, visual acuity, OCT findings, previous response, availability and patient-specific considerations.
Treatment may involve an initial series of injections followed by an individualised monitoring and retreatment strategy. Some patients require repeated injections, while others may achieve stability with fewer treatments.
The response should be assessed clinically and with OCT rather than following a fixed injection schedule without reassessment.
Read more about intravitreal anti-VEGF injections and their role in retinal diseases.
3. Pan-Retinal Photocoagulation (PRP)
PRP is an important treatment for proliferative diabetic retinopathy.
The procedure applies laser burns to selected peripheral areas of the retina. Its purpose is to reduce the stimulus for abnormal new blood vessel growth and lower the risk of complications such as vitreous haemorrhage.
PRP may be performed over more than one session depending on the patient's condition and the extent of treatment required.
It is important to explain that PRP does not restore damaged retinal tissue or reverse all existing visual loss. It is intended to reduce the risk of further complications.
4. Vitreoretinal Surgery in Advanced Disease
Some patients present with advanced diabetic eye disease, particularly when there is:
Persistent or non-clearing vitreous haemorrhage.
Tractional retinal detachment involving or threatening the macula.
Combined retinal detachment.
Significant fibrovascular proliferation.
These cases may require pars plana vitrectomy or other vitreoretinal surgical procedures.
Timely identification and referral are essential when surgical intervention is indicated.
A Clinical Example: Severe NPDR with Diabetic Macular Oedema
A clinical case documented on this website involved a 55-year-old male with a 15-year history of type 2 diabetes and an HbA1c of 9.4%.
Fundus examination showed multiple deep-blot haemorrhages, cotton-wool spots, venous beading and intraretinal microvascular abnormalities, consistent with severe NPDR.
OCT assessment confirmed centre-involved diabetic macular oedema.
The patient was managed with intravitreal ranibizumab, along with advice for improved systemic risk-factor control and coordination with the treating physician.
View the clinical case: Severe NPDR with centre-involved diabetic macular oedema.
Clinical cases illustrate why diabetic retinopathy should be assessed using both retinal examination and appropriate imaging. The treatment plan must address the specific retinal changes rather than relying only on the duration of diabetes or HbA1c value.
When Should a Person with Diabetes Get a Retina Examination?
The absence of symptoms does not rule out diabetic retinopathy.
In general:
People with type 2 diabetes should have a retinal examination at the time of diagnosis.
People with type 1 diabetes should generally undergo their first screening within five years of diagnosis, with timing adjusted for age and clinical circumstances.
During pregnancy in a woman with pre-existing diabetes, retinal assessment should be arranged before conception or early in pregnancy, with follow-up determined by the findings.
Subsequent examination intervals depend on the type of diabetes, retinopathy grade, macular involvement, pregnancy status and other risk factors.
Patients with established diabetic retinopathy may require reviews more frequently than once a year.
Sudden blurring of vision, new floaters, a sudden shower of dark spots or a curtain-like shadow should prompt urgent retinal evaluation rather than waiting for the next routine screening appointment.
Why Individualised Treatment and Regular Follow-Up Matter
Diabetic retinopathy is a progressive disease, but its course is not identical in every patient.
Two patients with similar diabetes duration may have very different retinal findings. One may have mild NPDR requiring periodic monitoring, while another may have severe NPDR, macular oedema or proliferative disease requiring active treatment.
Similarly, not every patient with macular oedema needs an immediate injection, and not every patient with retinal haemorrhages needs laser treatment.
The purpose of a detailed retinal evaluation is to identify:
The exact stage of diabetic retinopathy.
Whether the macula is involved.
Whether retinal ischaemia or neovascularisation is present.
Whether immediate treatment is required.
What follow-up interval is appropriate.
A careful, imaging-guided and evidence-based approach helps avoid both delayed treatment and unnecessary intervention.
Diabetic Retinopathy Evaluation in Varanasi
Dr. Shantanu Kumar Gupta is a consultant ophthalmologist with a focus on cataract, cornea and medical retina care. His training includes MBBS, MS from Maulana Azad Medical College, DNB and FICO (Merit), with further training at Guru Nanak Eye Centre, New Delhi.
At Shantanu Netralaya Eye Hospital, Varanasi, diabetic retinal evaluation and management may include dilated retinal examination, OCT, fundus photography, selected angiographic investigations, intravitreal injections and retinal laser treatment, depending on the patient's diagnosis.
For patients from Varanasi and neighbouring districts of Purvanchal, the aim is to provide a clear diagnosis, explain the stage of retinal disease and recommend treatment only when clinically indicated.
For more information, visit:
Consultation: Shantanu Netralaya Eye Hospital, 40 Deen Dayal Colony, Kabir Nagar Road, near Durgakund, Varanasi.
Appointment: +91 83186 65154
Frequently Asked Questions
1. Can diabetic retinopathy occur even when blood sugar is controlled?
Yes. Good glucose control reduces the risk of progression, but it does not completely eliminate the possibility of diabetic retinopathy. Retinal screening remains important.
2. Can diabetic retinopathy be present without blurred vision?
Yes. Early and even some advanced stages may not produce noticeable symptoms. A dilated retinal examination is necessary to detect the disease.
3. Does every patient with diabetic retinopathy need an injection?
No. Injections are used for specific indications, particularly diabetic macular oedema and selected cases of proliferative disease. Many patients require observation and systemic risk-factor control instead.
4. Is OCT necessary in diabetic retinopathy?
OCT is particularly useful for detecting and monitoring diabetic macular oedema. It provides detailed structural information about the macula and helps assess treatment response.
5. Can retinal laser restore vision lost due to diabetes?
Laser is primarily used to reduce the risk of further retinal complications, especially in proliferative diabetic retinopathy. It cannot reliably reverse established retinal damage or restore all lost vision.
6. Can diabetic retinopathy cause sudden blindness?
Yes. Complications such as vitreous haemorrhage or retinal detachment can cause sudden or severe visual loss. Sudden changes in vision require urgent evaluation.
7. How often should a diabetic patient undergo an eye examination?
The interval depends on the retinal findings and individual risk factors. People with no retinopathy may be reviewed at longer intervals, while patients with established disease often need more frequent monitoring.
Medical disclaimer: This article is intended for patient education and general information. It does not replace a clinical examination or personalised medical advice. Diagnosis and treatment decisions should be made by a qualified ophthalmologist after evaluating the individual patient.
This article is for patient education. It is not a substitute for personalised medical advice, examination or diagnosis. If you have symptoms discussed here, please book an in-person consultation with a qualified ophthalmologist.
Dr. Shantanu personally reviews every enquiry — usually within a few hours.
Message on WhatsApp
Consultant Ophthalmologist at Shantanu Netralaya Eye Hospital, Varanasi. New Delhi (MAMC / Guru Nanak Eye Centre) trained cataract, cornea and medical retina specialist. FICO (Merit).